Synergistic drug strategy against mastitis-associated MRSA strains

VAN combined with OXA or RIF exhibited robust synergy against mastitis-linked MDR-MRSA in vitro and in vivo. These findings highlight that the combination of VAN with OXA or RIF could be a promising strategy for treating mastitis caused by drug-resistant MRSA.

Authors

Yao Li (ORCID: https://orcid.org/0000-0001-8323-4918)
Xiaoyan Li (ORCID: https://orcid.org/0000-0002-9806-1850)
Lai Qian

Institutions

Second Affiliated Hospital of Zhejiang University (CN)

Publication Details

Journal: Future Microbiology
Published: 2025-10-13
DOI: https://doi.org/10.1080/17460913.2025.2574640
Primary Topic: Antimicrobial Resistance in Staphylococcus
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Synergistic drug strategy against mastitis-associated MRSA strains

Yao Li, Xiaoyan Li, Lai Qian

Oct 13, 2025

Future Microbiology

Antimicrobial Resistance in Staphylococcus

article

Synergistic drug strategy against mastitis-associated MRSA strains

Yao Li, Xiaoyan Li, Lai Qian

October 13, 2025article en

Abstract

Future MicrobiologyVol. 20(15)

Second Affiliated Hospital of Zhejiang University (CN)

Openalex Percentile: Top 66%

Antimicrobial Resistance in Staphylococcus

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Synergistic drug strategy against mastitis-associated MRSA strains — Yao Li, Xiaoyan Li, et al. · Future Microbiology (2025) | TGRS Research Map | TGRS